The independent impact of extended pattern biopsy on prostate cancer stage migration

Journal of Urology

Volumn 174, Issue 5, 2005, Pages 1789-1793

  Master, Viraj A ^a   Chi, Thomas ^c   Simko, Jeffrey P ^a   Weinberg, Vivian ^b   Carroll, Peter R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Biopsy; Prostate; Prostatic neoplasms; Tumor burden

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DATA BASE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; REVIEW; STATISTICAL ANALYSIS; TUMOR BIOPSY; TUMOR VOLUME;

EID: 27544442151     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000177465.11299.02     Document Type: Article

References (22)

1. Draisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A., Schroder, F. H. et al: Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst, 95: 868, 2003
2. Hodge, K. K., McNeal, J. E., Terris, M. K. and Stamey, T. A.: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol, 142: 71, 1989
3. Stamey, T. A.: Making the most out of six systematic sextant biopsies. Urology, 45: 2, 1995
4. Presti, J. C., Jr.: Prostate biopsy: how many cores are enough? Urol Oncol, 21: 135, 2003
5. McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol, 12: 897, 1988
6. Rabbani, F., Stroumbakis, N., Kava, B. R., Cookson, M. S. and Fair, W. R.: Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol, 159: 1247, 1998
7. Noguchi, M., Stamey, T. A., McNeal, J. E. and Yemoto, C. E.: Assessment of morphometric measurements of prostate carcinoma volume. Cancer, 89: 1056, 2000
8. Presti, J. C., Jr., O'Dowd, G. J., Miller, M. C., Mattu, R. and Veltri, R. W.: Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol, 169: 125, 2003
9. Makhlouf, A. A., Krupski, T. L., Kunkle, D. and Theodorescu, D.: The effect of sampling more cores on the predictive accuracy of pathological grade and tumour distribution in the prostate biopsy. BJU Int, 93: 271, 2004
10. San Francisco, I. F., DeWolf, W. C., Rosen, S., Upton, M. and Olumi, A. F.: Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol, 169: 136, 2003
11. Sofer, M., Savoie, M., Kim, S. S., Civantos, F. and Soloway, M. S.: Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. J Urol, 169: 153, 2003
12. Stamey, T. A., McNeal, J. E., Yemoto, C. M., Sigal, B. M. and Johnstone, I. M.: Biological determinants of cancer progression in men with prostate cancer. JAMA, 281: 1395, 1999
13. McNeal, J. E., Villers, A. A., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer, 66: 1225, 1990
14. Partin, A. W., Epstein, J. I., Cho, K. R., Gittelsohn, A. M. and Walsh, P. C.: Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol, 141: 341, 1989
15. Palisaar, R. J., Graefen, M., Karakiewicz, P. I., Hammerer, P. G., Huland, E., Haese, A. et al: Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. Eur Urol, 41: 155, 2002
16. Epstein, J. I., Carmichael, M., Partin, A. W. and Walsh, P. C.: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol, 149: 1478, 1993
17. Lerner, S. E., Blute, M. L. and Zincke, H.: Risk factors for progression in patients with prostate cancer treated with radical prostatectomy. Semin Urol Oncol, 14: 12, 1996
18. Salomon, L., Levrel, O., Anastasiadis, A. G., Irani, J., De La Taille, A., Saint, F. et al: Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol, 43: 39, 2003
19. Chan, T. Y., Chan, D. Y., Stutzman, K. L. R. E. and Epstein, J. I.: Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J Urol, 166: 2181, 2001
20. Brossner, C., Bayer, G., Madersbacher, S., Kuber, W., Klingler, C. and Pycha, A.: Twelve prostate biopsies detect significant cancer volumes (> 0.5 mL). BJU Int, 85: 705, 2000
21. Eskew, L. A., Woodruff, R. D., Bare, R. L. and McCullough, D. L.: Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J Urol, 160: 794, 1998
22. Grossklaus, D. J., Coffey, C. S., Shappell, S. B., Jack, G. S. and Cookson, M. S.: Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores. BJU Int, 88: 722, 2001